

Fundamental dimension Equity attribute | ADIPeer $391.07▲+1.38% Cap $189.5BP/E 46.2x QuantScore67/100 | ALGMPeer $31.48▼-0.66% Cap $5.87BP/E 388.6x QuantScore52/100 | CRUSLeader $112.32▲+1.66% Cap $5.63BP/E 13.3x QuantScore68/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
68/100 |
25/100 |
56/100 |
Valuation Multiples, PEG & DCF upside | 42/100 | 20/100 | 99/100 |
Health Piotroski, Altman Z, leverage & liquidity | 77/100 | 75/100 | 100/100 |
Growth Revenue / earnings growth & margins | 64/100 | 59/100 | 31/100 |
Sentiment Analyst ratings, targets & revisions | 85/100 | 83/100 | 52/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 46.2x | 388.6x | 13.3x |
Forward P/E (next FY) | 30.4x | 30.6x | 13.3x |
EV / EBITDA (TTM) | 28.0x | 57.7x | 9.0x |
Price / Sales | 13.7x | 6.2x | 2.7x |
Price / Free Cash Flow | 38.4x | 66.4x | 9.8x |
PEG ratio | 0.40 | 0.72 | 0.48 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 7 / 9 | 8 / 9 |
Altman Z-Score | 8.67 (Safe) | 8.91 (Safe) | 11.27 (Safe) |
Total debt / equity | 0.27 | 0.30 | 0.08 |
Quick ratio | 0.9x | 2.3x | 6.2x |
Interest coverage | 14.1x | 2.2x | 471.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +16.9% | +22.8% | +5.3% |
Net income growth YoY | +38.7% | +79.6% | +25.0% |
Gross margin (TTM) | 65.8% | 47.2% | 52.8% |
Operating margin (FY) | 26.6% | 4.8% | 23.0% |
FCF margin (FY) | 38.8% | 14.0% | 31.9% |
5. Trailing price performancePrice change over period |
1M return | +2.2% | -10.4% | -5.5% |
3M return | +5.2% | -31.6% | -15.9% |
6M return | -2.1% | -28.7% | -35.5% |
Year to date | +44.2% | +19.3% | -5.2% |
1Y return | +64.3% | +1.8% | -14.0% |
3Y return | +137.1% | +9.4% | +67.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $172.35 -55.9% premium | $3.39 -89.2% premium | $156.92 +39.7% upside |
Wall Street consensus target | $480.24 +22.8% · range $405.00–$675.00 | $54.00 +71.5% · range $45.00–$67.00 | $160.00 +42.5% · range $130.00–$190.00 |
Consensus stance | 83% Buy17% Hold-0% Sell | 92% Buy8% Hold0% Sell | 64% Buy23% Hold14% Sell |